Ikena Oncology Inc
NASDAQ:IKNA
Ikena Oncology Inc
NASDAQ:IKNA
Price:
1.32 USD
Market Closed
Updated:
May 4, 2024
Ikena Oncology Inc
Cash from Investing Activities
|
Ikena Oncology Inc
Cash from Investing Activities Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Ikena Oncology Inc
NASDAQ:IKNA
|
Cash from Investing Activities
$64.1m
|
CAGR 3-Years
180%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Investing Activities
-$2.9B
|
CAGR 3-Years
48%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Investing Activities
-$21.7B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Investing Activities
-$32.3B
|
CAGR 3-Years
-76%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Investing Activities
-$14.1B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Investing Activities
-$7.6B
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-10%
|
See Also
What is Ikena Oncology Inc's Cash from Investing Activities?
Cash from Investing Activities
64.1m
USD
64.1m
USD
Based on the financial report for Dec 31, 2023, Ikena Oncology Inc's Cash from Investing Activities amounts to 64.1m USD.
What is Ikena Oncology Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
42%
42%
The average annual Cash from Investing Activities growth rates for Ikena Oncology Inc have been 180% over the past three years , 42% over the past five years .
You don't have any saved screeners yet
